Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (CrossMab) is designed to be expressed as three chains derived from the variable domains of anti-CA72-4 and anti-CD3 parental antibodies. It contains a His-tag for affinity purification. And the two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CA72-4 x Anti-CD3 Bispecific Antibody (CrossMab) (CROSSAB-H202). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS